arrow
K

Kevin J. Whitehead

University of Utah
H指数:42
被引数:7,353

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characteristics Associated with Clinical Response to Pomalidomide in Hereditary Hemorrhagic Telangiectasia

与帕母利度胺临床反应相关的特征:遗传性出血性毛细血管扩张症

2026-02-240
OAAI
Validation and Clinical Application of the Hereditary Hemorrhagic Telangiectasia-Specific Quality of Life Scale (HHT-QoL)

《遗传性出血性毛细血管扩张症特异性生活质量量表(HHT-QoL)的验证与临床应用》

2025-10-130
PRE
Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia

Pomalidomide用于遗传性出血性毛细血管扩张症的鼻出血

2024-09-192
PRE
Reply to Eker et al. Comment on Kilian et al. Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT. J. Clin. Med. 2023, 12, 2704

回复Eker等人。评论Kilian等人。比较HHT儿童和成人脑血管畸形的特征和治疗。J.Clin.医学。2023,12,2704

2023-12-010
OAAI
Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-β Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice

无义变异PRDM16-Q187X导致心肌发育受损和tgf-β 信号传导,导致人和小鼠心肌致密化不全心肌病

2023-12-013
PRE
Cardiac-specific deletion of voltage dependent anion channel 2 leads to dilated cardiomyopathy by altering calcium homeostasis
2021-07-2832
OAAI
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia
2020-12-15261
PREAI
Genotype-Phenotype Correlations in Children with HHT
2020-08-2218
OAAI
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial
2019-12-0158
OAAI
Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation
2019-11-2759
OAAI